BTAIVSNGNE• 28 Days (Normalized)
BTAI vs NGNE (BioXcel Therapeutics Inc. vs Neurogene Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-95.71%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
NGNE Performance $35.48
-1.83%
Neurogene Inc.
Normalized Baseline0.00%
Alpha Spread Margin NGNE LEADS
-93.88%
NGNE outperforming by 93.88%
BTAINGNE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI NGNE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BTAI Price | BTAI Gain (%) | NGNE Price | NGNE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -95.71% | $35.48 | -1.83% | -93.88% |
| Sep 10, 2026 | $0.05 | -95.80% | $36.12 | -0.06% | -95.74% |
| Sep 09, 2026 | $0.05 | -96.05% | $37.88 | +4.81% | -100.86% |
| Sep 08, 2026 | $0.04 | -96.39% | $38.13 | +5.51% | -101.90% |
| Sep 04, 2026 | $0.07 | -93.79% | $38.60 | +6.81% | -100.60% |
| Sep 03, 2026 | $0.12 | -90.08% | $37.61 | +4.07% | -94.15% |
| Sep 02, 2026 | $0.11 | -91.01% | $38.36 | +6.14% | -97.15% |
| Sep 01, 2026 | $0.14 | -88.49% | $37.87 | +4.79% | -93.28% |
| Aug 31, 2026 | $0.16 | -86.30% | $36.24 | +0.28% | -86.58% |
| Aug 28, 2026 | $0.18 | -84.79% | $36.58 | +1.22% | -86.01% |
| Aug 27, 2026 | $0.72 | -39.58% | $37.86 | +4.76% | -44.34% |
| Aug 26, 2026 | $0.78 | -34.45% | $38.41 | +6.28% | -40.73% |
| Aug 25, 2026 | $0.74 | -37.65% | $40.84 | +13.00% | -50.65% |
| Aug 24, 2026 | $0.76 | -36.05% | $39.64 | +9.68% | -45.73% |
| Aug 21, 2026 | $0.80 | -32.44% | $38.63 | +6.89% | -39.33% |
Page 1 of 2